Mingjie Lu

794 total citations
25 papers, 556 citations indexed

About

Mingjie Lu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Mingjie Lu has authored 25 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Mingjie Lu's work include MicroRNA in disease regulation (3 papers), Spaceflight effects on biology (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Mingjie Lu is often cited by papers focused on MicroRNA in disease regulation (3 papers), Spaceflight effects on biology (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Mingjie Lu collaborates with scholars based in China, Australia and United States. Mingjie Lu's co-authors include Wei Zhu, Dong Yang, Yingjie Wang, Zhaowei Liu, Ping Liu, Peng Cao, Yongqian Shu, Min Huang, Hao Wu and Shidai Jin and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Sustainability.

In The Last Decade

Mingjie Lu

24 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingjie Lu China 12 230 166 116 69 65 25 556
Yafei Wang China 13 264 1.1× 157 0.9× 123 1.1× 69 1.0× 29 0.4× 32 586
Ge Zhang China 13 321 1.4× 92 0.6× 95 0.8× 59 0.9× 30 0.5× 26 559
H. Zhong United States 14 278 1.2× 121 0.7× 101 0.9× 117 1.7× 66 1.0× 32 630
Jinxian Chen China 14 316 1.4× 207 1.2× 114 1.0× 55 0.8× 72 1.1× 33 596
Weixun Chen China 17 387 1.7× 220 1.3× 134 1.2× 100 1.4× 67 1.0× 36 749
Shaochuang Wang China 14 288 1.3× 114 0.7× 60 0.5× 46 0.7× 28 0.4× 24 589
Simon Chen United States 15 177 0.8× 110 0.7× 97 0.8× 105 1.5× 118 1.8× 28 782
Mingyu Du China 19 449 2.0× 384 2.3× 81 0.7× 76 1.1× 66 1.0× 58 814
Jiaxin Xie China 15 246 1.1× 191 1.2× 108 0.9× 36 0.5× 63 1.0× 62 1.1k

Countries citing papers authored by Mingjie Lu

Since Specialization
Citations

This map shows the geographic impact of Mingjie Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjie Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjie Lu more than expected).

Fields of papers citing papers by Mingjie Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjie Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjie Lu. The network helps show where Mingjie Lu may publish in the future.

Co-authorship network of co-authors of Mingjie Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjie Lu. A scholar is included among the top collaborators of Mingjie Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjie Lu. Mingjie Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Meijun, et al.. (2024). Resveratrol by elevating the SIRT1 BDNF, GDNF and PSD95 levels reduce heroin addiction related behaviors. Neuroscience Letters. 841. 137934–137934. 3 indexed citations
2.
Chen, Yunyun, et al.. (2024). Research on Air-Gap Field Modulation Effect of Torque Enhanced Hybrid Permanent Magnet Motor. IEEE Transactions on Magnetics. 60(9). 1–6. 1 indexed citations
4.
Liu, Ji, Dehua Tang, Li Zhang, et al.. (2024). UPDP: A Unified Progressive Depth Pruner for CNN and Vision Transformer. Proceedings of the AAAI Conference on Artificial Intelligence. 38(12). 13891–13899. 1 indexed citations
6.
Liu, Zhaowei, et al.. (2023). EGNN: Graph structure learning based on evolutionary computation helps more in graph neural networks. Applied Soft Computing. 135. 110040–110040. 81 indexed citations
7.
Xie, Bo, Hongyan Yuan, Mingjie Lu, et al.. (2023). p75NTR promotes tooth rhythmic mineralization via upregulation of BMAL1/CLOCK. Frontiers in Cell and Developmental Biology. 11. 1283878–1283878.
8.
Lu, Mingjie, et al.. (2023). Artificial intelligence in dentistry: A bibliometric analysis from 2000 to 2023. Journal of Dental Sciences. 19(3). 1722–1733. 17 indexed citations
9.
Chen, Xiaofeng, Xiang Xu, Danping Wang, et al.. (2023). Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial. Journal for ImmunoTherapy of Cancer. 11(2). e005830–e005830. 54 indexed citations
10.
Yuan, Hongyan, Bo Xie, Meng Li, et al.. (2022). A potential role of p75NTR in the regulation of circadian rhythm and incremental growth lines during tooth development. Frontiers in Physiology. 13. 981311–981311. 3 indexed citations
11.
Lu, Mingjie, et al.. (2022). Analysis of Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 161 Patients: A Retrospective Study. International Journal of General Medicine. Volume 15. 8617–8625. 6 indexed citations
12.
Li, Xiaofei, Mingjie Lu, Jing Ye, et al.. (2022). CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy. OncoImmunology. 11(1). 2118210–2118210. 54 indexed citations
13.
Lu, Mingjie, Linlin Yan, Minghui Ge, et al.. (2021). A Pan-Cancer Analysis of Predictive Methylation Signatures of Response to Cancer Immunotherapy. Frontiers in Immunology. 12. 796647–796647. 21 indexed citations
14.
Wang, Shaofeng, et al.. (2021). Determinants of Active Online Learning in the Smart Learning Environment: An Empirical Study with PLS-SEM. Sustainability. 13(17). 9923–9923. 40 indexed citations
15.
Li, Jun, Mingjie Lu, Jin Jiao, et al.. (2018). miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22. Cellular Physiology and Biochemistry. 50(1). 136–149. 40 indexed citations
16.
Lu, Mingjie, Tongshan Wang, Mingfeng He, et al.. (2017). Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer. Oncotarget. 8(14). 23008–23019. 15 indexed citations
17.
Wang, He, et al.. (2016). Effects of treatment with an Hsp90 inhibitor in tumors based on 15 phase II clinical trials. Molecular and Clinical Oncology. 5(3). 326–334. 34 indexed citations
18.
Lu, Mingjie, Chen Wang, & Jian Wang. (2016). Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways. International Journal of Oncology. 49(2). 603–610. 30 indexed citations
19.
Lu, Mingjie, Jun Li, Zebo Huang, et al.. (2016). Aberrant Maspin mRNA Expression is Associated with Clinical Outcome in Patients with Pulmonary Adenocarcinoma. Medical Science Monitor. 22. 134–139. 5 indexed citations
20.
Wu, Hao, Min Huang, Mingjie Lu, et al.. (2013). Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Cancer Chemotherapy and Pharmacology. 71(5). 1159–1171. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026